The end of a period. In a decree dated Thursday, February 13 and published on Saturday, February 22, the Ministry of Health indicates that as of March 1, the COVVI-19 detection tests in Pharmacy are no longer reimbursed by health insurance.
This document repeals the decree of June 1, 2021, which is related “to the organization and the operational measures of the health system maintained in the fight against COVID-19”, which provided the reimbursement of these tests, or around 16.50 euros.
This decision, on the other hand, does not worry “the elderly or people with long -term affection” that, as indicated by the public service site, will continue to benefit from this refund, but only of the medical recipe.
Critics of professionals
In a statement published on Wednesday, January 15, two days after the signing of the Decree, the Union of Frame Pharmacists Unions (OPPO) denounced the cessation of these reimbursements while France crosses a Winter epidemics period.
“These measures come to a critical moment, in the midst of the flu epidemic and bronchiolitis in France, while hospitals are already saturated, than White plans are multiplying And that medical offices are still struggling to absorb the patient’s demand, “said the press release.
In BFMTV, the General Health Directorate indicates that, for this decision, the Ministry of Health wishes to incorporate “the National Strategy for Prevention and Management related to acute respiratory infections of viral origin (IRA), including the COVVI-19, (…) in customary law.”
Since February 2023, the Antigenic tests COVVI-19 They are the only rapid tests, which detect acute respiratory infections, to be reimbursed in part by health insurance.
Source: BFM TV
